You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 9, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Jacques Friborg1, Baiqing Lin, Chaoqun Chen
1Discovery Virology, Bristol-Myers Squibb Research and Development, Wallingford, CT 06492, USA. jacques.friborg@bms.com
Investigating non-response to pegylated interferon lambda-1a (Lambda) for hepatitis C virus (HCV), this study identified defects in the JAK-STAT pathway in resistant HCV cells. This explains reduced antiviral responses to interferon lambda-1.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: